Timelines matter. At Veloxity Labs, we were built from the ground up to move faster than traditional bioanalytical CROs — without ever cutting corners.
In drug development, time is a critical variable. Delays in data can derail timelines, stall decision-making and drive up costs. At Veloxity Labs, rapid turnaround isn’t a bonus — it’s our baseline. We specialize in rapid, reliable bioanalysis — helping you stay on track, hit milestones and bring life-changing therapies to market faster.
Across the industry, long backlog queues, operational inefficiencies and capacity bottlenecks can leave sponsors stuck, often waiting six months or more just to get started on their project with a CRO. With 80% lab capacity reserved for rapid response, we eliminate the wait time and deliver our initial insights to you in days — not months.
While other CROs take weeks to start, Veloxity Labs launches most projects in just five days. Our streamlined, resource-ready model gets you generating data — fast, with no backlogs or delays.
Your ability to make informed decisions depends on timely insights. Our fast turnaround means fewer delays between dosing and data — so you can adjust, pivot or advance with confidence at every step.
Waiting for results can hide critical issues. Our accelerated timelines help identify safety signals, interactions or formulation problems early — before they spiral into costly delays or failed studies down the line.
Extended delays lead to idle resources, wasted spend and timeline creep. With Veloxity Labs' rapid turnaround, your team can align efforts, avoid bottlenecks and control project costs more effectively.
Every day counts when bringing new treatments to market. Faster bioanalytical data accelerates approvals, unlocks next-phase readiness and gives your program a strategic advantage.
At Veloxity, speed and quality go hand-in-hand. Our validated workflows, rigorous QA processes and experienced team ensure every data point is accurate, defensible and audit-ready — no shortcuts, no compromises.
Download our report to explore the importance of bioanalytical turnaround times, why they matter to your project timelines and how Veloxity’s commitment to scalability and efficiency enables us to deliver faster results without sacrificing quality. By examining industry averages, turnaround time drivers and key operational strategies, we’ll show you how we’re able to initiate new projects in just five business days — giving you the fast, reliable bioanalytical insights you need to keep your research and development on track.
